State of the science on mild cognitive impairment (MCI)

Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10–15% of the population over the age of 65. The failure of drug trials in Alzheimer’s disease (AD) treatment has shifted researchers’ focus toward delaying progression from MCI to dementi...

Full description

Saved in:

Bibliographic Details
Published in:	CNS spectrums Vol. 24; no. 1; pp. 78 - 87
Main Author:	Anderson, Nicole D.
Format:	Journal Article
Language:	English
Published:	United States Cambridge University Press 01.02.2019
Subjects:	Alzheimer's disease Apolipoproteins - genetics Apolipoproteins - metabolism Biomarkers Cognitive Dysfunction - drug therapy Cognitive Dysfunction - genetics Cognitive Dysfunction - metabolism Cognitive Dysfunction - physiopathology Cortical Excitability Humans Mental depression Nootropic Agents - therapeutic use Older people neuropsychological assessment exercise and diet interventions biomarkers tau Amyloid mild cognitive impairment memory strategy training neuroimaging
ISSN:	1092-8529, 2165-6509
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10–15% of the population over the age of 65. The failure of drug trials in Alzheimer’s disease (AD) treatment has shifted researchers’ focus toward delaying progression from MCI to dementia, which would reduce the prevalence and costs of dementia profoundly. Diagnostic criteria for MCI increasingly emphasize the need for positive biomarkers to detect preclinical AD. The phenomenology of MCI comprises lower quality-of-life, greater symptoms of depression, and avoidant coping strategies including withdrawal from social engagement. Neurobiological features of MCI are hypoperfusion and hypometabolism in temporoparietal cortices, medial temporal lobe atrophy particularly in rhinal cortices, elevated tau and phosphorylated tau and decreased Aβ 42 in cerebrospinal fluid, and brain Aβ 42 deposition. Elevated tau can be identified in MCI, particularly in the entorhinal cortex, using positron emission tomography, and analysis of signal complexity using electroencephalography or magnetoencephalography holds promise as a biomarker. Assessment of MCI also relies on cognitive screening and neuropsychological assessment, but there is an urgent need for standardized cognitive tests to capitalize on recent discoveries in cognitive neuroscience that may lead to more sensitive measures of MCI. Cholinesterase inhibitors are frequently prescribed for MCI, despite the lack of evidence for their efficacy. Exercise and diet interventions hold promise for increasing reserve in MCI, and group psychoeducational programs teaching practical memory strategies appear effective. More work is needed to better understand the phenomenology and neurobiology of MCI, and how best to assess it and delay progression to dementia.
AbstractList	Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10–15% of the population over the age of 65. The failure of drug trials in Alzheimer’s disease (AD) treatment has shifted researchers’ focus toward delaying progression from MCI to dementia, which would reduce the prevalence and costs of dementia profoundly. Diagnostic criteria for MCI increasingly emphasize the need for positive biomarkers to detect preclinical AD. The phenomenology of MCI comprises lower quality-of-life, greater symptoms of depression, and avoidant coping strategies including withdrawal from social engagement. Neurobiological features of MCI are hypoperfusion and hypometabolism in temporoparietal cortices, medial temporal lobe atrophy particularly in rhinal cortices, elevated tau and phosphorylated tau and decreased Aβ42 in cerebrospinal fluid, and brain Aβ42 deposition. Elevated tau can be identified in MCI, particularly in the entorhinal cortex, using positron emission tomography, and analysis of signal complexity using electroencephalography or magnetoencephalography holds promise as a biomarker. Assessment of MCI also relies on cognitive screening and neuropsychological assessment, but there is an urgent need for standardized cognitive tests to capitalize on recent discoveries in cognitive neuroscience that may lead to more sensitive measures of MCI. Cholinesterase inhibitors are frequently prescribed for MCI, despite the lack of evidence for their efficacy. Exercise and diet interventions hold promise for increasing reserve in MCI, and group psychoeducational programs teaching practical memory strategies appear effective. More work is needed to better understand the phenomenology and neurobiology of MCI, and how best to assess it and delay progression to dementia. Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10–15% of the population over the age of 65. The failure of drug trials in Alzheimer’s disease (AD) treatment has shifted researchers’ focus toward delaying progression from MCI to dementia, which would reduce the prevalence and costs of dementia profoundly. Diagnostic criteria for MCI increasingly emphasize the need for positive biomarkers to detect preclinical AD. The phenomenology of MCI comprises lower quality-of-life, greater symptoms of depression, and avoidant coping strategies including withdrawal from social engagement. Neurobiological features of MCI are hypoperfusion and hypometabolism in temporoparietal cortices, medial temporal lobe atrophy particularly in rhinal cortices, elevated tau and phosphorylated tau and decreased Aβ 42 in cerebrospinal fluid, and brain Aβ 42 deposition. Elevated tau can be identified in MCI, particularly in the entorhinal cortex, using positron emission tomography, and analysis of signal complexity using electroencephalography or magnetoencephalography holds promise as a biomarker. Assessment of MCI also relies on cognitive screening and neuropsychological assessment, but there is an urgent need for standardized cognitive tests to capitalize on recent discoveries in cognitive neuroscience that may lead to more sensitive measures of MCI. Cholinesterase inhibitors are frequently prescribed for MCI, despite the lack of evidence for their efficacy. Exercise and diet interventions hold promise for increasing reserve in MCI, and group psychoeducational programs teaching practical memory strategies appear effective. More work is needed to better understand the phenomenology and neurobiology of MCI, and how best to assess it and delay progression to dementia. Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10-15% of the population over the age of 65. The failure of drug trials in Alzheimer's disease (AD) treatment has shifted researchers' focus toward delaying progression from MCI to dementia, which would reduce the prevalence and costs of dementia profoundly. Diagnostic criteria for MCI increasingly emphasize the need for positive biomarkers to detect preclinical AD. The phenomenology of MCI comprises lower quality-of-life, greater symptoms of depression, and avoidant coping strategies including withdrawal from social engagement. Neurobiological features of MCI are hypoperfusion and hypometabolism in temporoparietal cortices, medial temporal lobe atrophy particularly in rhinal cortices, elevated tau and phosphorylated tau and decreased Aβ42 in cerebrospinal fluid, and brain Aβ42 deposition. Elevated tau can be identified in MCI, particularly in the entorhinal cortex, using positron emission tomography, and analysis of signal complexity using electroencephalography or magnetoencephalography holds promise as a biomarker. Assessment of MCI also relies on cognitive screening and neuropsychological assessment, but there is an urgent need for standardized cognitive tests to capitalize on recent discoveries in cognitive neuroscience that may lead to more sensitive measures of MCI. Cholinesterase inhibitors are frequently prescribed for MCI, despite the lack of evidence for their efficacy. Exercise and diet interventions hold promise for increasing reserve in MCI, and group psychoeducational programs teaching practical memory strategies appear effective. More work is needed to better understand the phenomenology and neurobiology of MCI, and how best to assess it and delay progression to dementia.Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10-15% of the population over the age of 65. The failure of drug trials in Alzheimer's disease (AD) treatment has shifted researchers' focus toward delaying progression from MCI to dementia, which would reduce the prevalence and costs of dementia profoundly. Diagnostic criteria for MCI increasingly emphasize the need for positive biomarkers to detect preclinical AD. The phenomenology of MCI comprises lower quality-of-life, greater symptoms of depression, and avoidant coping strategies including withdrawal from social engagement. Neurobiological features of MCI are hypoperfusion and hypometabolism in temporoparietal cortices, medial temporal lobe atrophy particularly in rhinal cortices, elevated tau and phosphorylated tau and decreased Aβ42 in cerebrospinal fluid, and brain Aβ42 deposition. Elevated tau can be identified in MCI, particularly in the entorhinal cortex, using positron emission tomography, and analysis of signal complexity using electroencephalography or magnetoencephalography holds promise as a biomarker. Assessment of MCI also relies on cognitive screening and neuropsychological assessment, but there is an urgent need for standardized cognitive tests to capitalize on recent discoveries in cognitive neuroscience that may lead to more sensitive measures of MCI. Cholinesterase inhibitors are frequently prescribed for MCI, despite the lack of evidence for their efficacy. Exercise and diet interventions hold promise for increasing reserve in MCI, and group psychoeducational programs teaching practical memory strategies appear effective. More work is needed to better understand the phenomenology and neurobiology of MCI, and how best to assess it and delay progression to dementia.
Author	Anderson, Nicole D.
Author_xml	– sequence: 1 givenname: Nicole D. orcidid: 0000-0002-5979-2220 surname: Anderson fullname: Anderson, Nicole D.
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30651152$$D View this record in MEDLINE/PubMed
BookMark	eNp1kM1LxDAQxYMourv6B3iRghc9VDP5aNOjLH6B4mH1HLLpVLO06dqkgv-9WdTLiqdheL_3ZnhTsut7j4QcA70ACuXlAmjFlGQVKEqBi3KHTBgUMi8krXbJZCPnG_2ATENYUSp4qfg-OeC0kACSTUi5iCZi1jdZfMMsWIfeptVnnWvrzPav3kX3gZnr1sYNHfqYnT3O788PyV5j2oBHP3NGXm6un-d3-cPT7f386iG3gquYGysUCiVUhSU1toKmpuk24waRouGooFDLZaF4jUzi0tpaCFkIIxvDgAGfkbPv3PXQv48You5csNi2xmM_Bs2grARllagSerqFrvpx8Ok7zUqlQCaUJurkhxqXHdZ6PbjODJ_6t5IElN-AHfoQBmy0dakj1_s4GNdqoHpTvv5TfnLClvM3_H_PF489ggE
CitedBy_id	crossref_primary_10_1038_s41746_023_00987_5 crossref_primary_10_3389_fnagi_2025_1657074 crossref_primary_10_1017_S2045796020001183 crossref_primary_10_3390_healthcare13060589 crossref_primary_10_1080_23279095_2025_2527732 crossref_primary_10_3389_fpsyt_2024_1436499 crossref_primary_10_1177_07334648241248294 crossref_primary_10_1371_journal_pone_0326227 crossref_primary_10_3233_JAD_220762 crossref_primary_10_1097_MOL_0000000000000900 crossref_primary_10_3390_healthcare13161963 crossref_primary_10_3758_s13415_023_01093_5 crossref_primary_10_1016_j_taap_2024_117126 crossref_primary_10_3389_fnagi_2024_1460293 crossref_primary_10_3390_healthcare12161622 crossref_primary_10_1097_QAD_0000000000003556 crossref_primary_10_3389_fnagi_2022_925855 crossref_primary_10_3390_ijerph19084508 crossref_primary_10_1177_15347354221096808 crossref_primary_10_1016_j_gerinurse_2021_09_013 crossref_primary_10_1080_13607863_2024_2341877 crossref_primary_10_1186_s13063_024_08001_3 crossref_primary_10_1007_s41999_021_00534_z crossref_primary_10_1016_j_jad_2024_11_029 crossref_primary_10_1177_25424823241290132 crossref_primary_10_1186_s12877_023_04162_z crossref_primary_10_1007_s40120_022_00335_x crossref_primary_10_11648_j_ijacm_20251302_11 crossref_primary_10_1016_j_nbd_2022_105800 crossref_primary_10_3389_fnhum_2023_1331436 crossref_primary_10_1016_j_neurobiolaging_2023_07_006 crossref_primary_10_1038_s41598_024_75010_2 crossref_primary_10_3233_JAD_220863 crossref_primary_10_3389_fnagi_2021_711023 crossref_primary_10_1080_0886022X_2023_2217276 crossref_primary_10_3390_ijerph192315454 crossref_primary_10_7759_cureus_69561 crossref_primary_10_3390_ijms241713395 crossref_primary_10_2147_RMHP_S519049 crossref_primary_10_1016_j_ejphar_2024_176750 crossref_primary_10_3389_fnagi_2022_932924 crossref_primary_10_1186_s12888_021_03495_6 crossref_primary_10_1177_13872877251321187 crossref_primary_10_1016_j_conctc_2023_101231 crossref_primary_10_3389_fendo_2024_1459585 crossref_primary_10_1186_s13041_023_01009_x crossref_primary_10_3390_jcm12124049 crossref_primary_10_1016_j_brainres_2025_149610 crossref_primary_10_1111_ejn_16511 crossref_primary_10_1080_13880209_2021_1900879 crossref_primary_10_1016_j_scib_2024_09_005 crossref_primary_10_1162_jocn_a_02116 crossref_primary_10_3390_healthcare12191945 crossref_primary_10_1093_jnen_nlaf051 crossref_primary_10_3389_fnagi_2023_1007436 crossref_primary_10_1038_d41586_022_00860_7 crossref_primary_10_3389_fpsyg_2024_1402894 crossref_primary_10_1002_alz_70069 crossref_primary_10_2196_59195 crossref_primary_10_1002_brb3_70597 crossref_primary_10_1186_s40035_023_00341_5 crossref_primary_10_3389_fnut_2025_1585111 crossref_primary_10_1186_s12889_023_17551_1 crossref_primary_10_1007_s10072_023_07028_9 crossref_primary_10_1371_journal_pone_0296710 crossref_primary_10_1177_14713012231162713 crossref_primary_10_3389_fnagi_2022_1034998 crossref_primary_10_3389_fpubh_2024_1407694 crossref_primary_10_3390_psychiatryint6020064 crossref_primary_10_1007_s12152_023_09522_5 crossref_primary_10_3233_ADR_230199 crossref_primary_10_2196_49147 crossref_primary_10_2147_PRBM_S447774 crossref_primary_10_1007_s11065_023_09624_0 crossref_primary_10_1016_j_expneurol_2024_114689 crossref_primary_10_3233_ADR_230191 crossref_primary_10_1177_15394492251331635 crossref_primary_10_1017_S1463423623000075 crossref_primary_10_1007_s11357_025_01850_z crossref_primary_10_1080_1028415X_2021_2017660 crossref_primary_10_3233_JAD_210479 crossref_primary_10_1007_s10495_025_02160_7 crossref_primary_10_1016_j_intimp_2025_114227 crossref_primary_10_1080_09637486_2023_2199182 crossref_primary_10_1111_ahg_70004 crossref_primary_10_1186_s12991_025_00566_w crossref_primary_10_3390_biom13071094 crossref_primary_10_1016_j_ecoenv_2025_118617 crossref_primary_10_1016_j_gerinurse_2025_103406 crossref_primary_10_1007_s40520_023_02668_5 crossref_primary_10_3389_fspor_2024_1368593 crossref_primary_10_1177_20552076241284810 crossref_primary_10_3389_fnins_2024_1360935 crossref_primary_10_3390_ijms23094610 crossref_primary_10_1002_trc2_12363 crossref_primary_10_3389_fnagi_2022_951146 crossref_primary_10_3390_diagnostics15111427 crossref_primary_10_3389_fpsyt_2024_1415113 crossref_primary_10_1002_alz_70128 crossref_primary_10_1007_s11682_023_00830_1 crossref_primary_10_1111_jebm_12632 crossref_primary_10_1038_s41398_022_02093_8 crossref_primary_10_3389_fnagi_2021_691423 crossref_primary_10_3389_fphar_2023_1233977 crossref_primary_10_3390_biomedicines11071789 crossref_primary_10_1038_s44400_025_00018_y crossref_primary_10_1371_journal_pone_0269795 crossref_primary_10_2196_64465 crossref_primary_10_3389_fneur_2024_1403785 crossref_primary_10_3389_fneur_2025_1540915 crossref_primary_10_1016_j_heares_2025_109430 crossref_primary_10_1016_j_arr_2022_101639 crossref_primary_10_1007_s00415_024_12500_3 crossref_primary_10_3390_ijms242316956 crossref_primary_10_4103_aip_aip_213_23 crossref_primary_10_3390_nu14173596 crossref_primary_10_1186_s12877_025_05967_w crossref_primary_10_2196_27156 crossref_primary_10_1007_s00521_023_08489_x crossref_primary_10_1016_j_osep_2025_07_002 crossref_primary_10_3389_fnagi_2025_1530046 crossref_primary_10_1097_MD_0000000000034979 crossref_primary_10_1002_alz_70395 crossref_primary_10_2196_63004 crossref_primary_10_1097_MD_0000000000027323 crossref_primary_10_3389_fnins_2023_1216215 crossref_primary_10_1016_j_gerinurse_2021_06_027 crossref_primary_10_30629_2618_6667_2025_23_1_6_17 crossref_primary_10_3233_JAD_220184 crossref_primary_10_2196_58337 crossref_primary_10_1002_jbio_202300215 crossref_primary_10_1016_j_etap_2024_104548 crossref_primary_10_3389_fnut_2024_1424614 crossref_primary_10_1016_j_ijpsycho_2025_112558 crossref_primary_10_1016_j_arr_2022_101741 crossref_primary_10_1016_j_bandc_2022_105892 crossref_primary_10_3389_fnagi_2025_1590783 crossref_primary_10_3390_nu15163519 crossref_primary_10_1016_j_isci_2025_111848 crossref_primary_10_1093_arclin_acac078 crossref_primary_10_3389_fnut_2022_1024627 crossref_primary_10_1002_mco2_362 crossref_primary_10_3389_fnagi_2023_1165908 crossref_primary_10_1038_s41598_020_76201_3 crossref_primary_10_3389_fnagi_2025_1522552 crossref_primary_10_3389_fpsyg_2022_994070 crossref_primary_10_1016_j_bspc_2023_105652 crossref_primary_10_1016_j_neurobiolaging_2022_11_004 crossref_primary_10_1186_s12889_024_19164_8 crossref_primary_10_1007_s11325_023_02843_y crossref_primary_10_1111_ggi_13992 crossref_primary_10_3233_JAD_231174 crossref_primary_10_1016_j_acra_2024_07_030 crossref_primary_10_23736_S1973_9087_24_08015_8 crossref_primary_10_3389_fragi_2025_1592464 crossref_primary_10_1016_j_clnesp_2025_03_034 crossref_primary_10_1177_15333175231190626 crossref_primary_10_2196_39513 crossref_primary_10_3389_fnagi_2022_1007629 crossref_primary_10_3390_ijerph191610387 crossref_primary_10_3389_fnhum_2022_810046 crossref_primary_10_3389_fnagi_2025_1661172 crossref_primary_10_1038_s41598_024_73099_z crossref_primary_10_1055_s_0044_1795115 crossref_primary_10_3389_fnut_2025_1492306 crossref_primary_10_1007_s10522_024_10154_2 crossref_primary_10_5334_tohm_812 crossref_primary_10_1186_s12984_024_01422_w crossref_primary_10_3389_fnins_2023_1301066 crossref_primary_10_1080_13803395_2021_1982867 crossref_primary_10_1177_10497315241301366 crossref_primary_10_1038_s41598_020_77296_4 crossref_primary_10_3389_fmed_2024_1305565 crossref_primary_10_3390_jcm13164695 crossref_primary_10_3389_fnagi_2023_1283243 crossref_primary_10_1002_ibra_12194 crossref_primary_10_1111_cns_13846 crossref_primary_10_1186_s12877_025_06030_4 crossref_primary_10_1186_s12868_022_00718_8 crossref_primary_10_2196_56883 crossref_primary_10_3233_JAD_220590 crossref_primary_10_3389_fneur_2021_670220 crossref_primary_10_3390_jcm12196190 crossref_primary_10_3389_fnagi_2023_1237469 crossref_primary_10_1016_j_gaitpost_2025_06_005 crossref_primary_10_1016_j_arr_2024_102526 crossref_primary_10_3390_brainsci14030278 crossref_primary_10_1159_000519453 crossref_primary_10_3389_fnins_2023_1136266 crossref_primary_10_1016_j_neuropsychologia_2023_108679 crossref_primary_10_1007_s10072_022_06129_1 crossref_primary_10_1016_j_arr_2023_102146 crossref_primary_10_1242_bio_056796 crossref_primary_10_20960_nh_05723 crossref_primary_10_3233_JAD_215568 crossref_primary_10_1016_j_jff_2025_106942 crossref_primary_10_3389_fneur_2021_719849 crossref_primary_10_3389_fnagi_2025_1496725 crossref_primary_10_1016_j_gerinurse_2024_10_053 crossref_primary_10_1007_s12369_024_01115_3 crossref_primary_10_3389_fnagi_2024_1461556 crossref_primary_10_1177_20552076231176648 crossref_primary_10_1016_j_ijbiomac_2025_145659 crossref_primary_10_1186_s44147_025_00674_0 crossref_primary_10_1016_j_micpath_2023_106272 crossref_primary_10_3389_fmed_2024_1432455 crossref_primary_10_3390_nu15214505 crossref_primary_10_3389_fpsyg_2022_1044385 crossref_primary_10_1016_j_imr_2022_100914 crossref_primary_10_1016_j_jtemb_2025_127712 crossref_primary_10_1002_pcn5_70134 crossref_primary_10_3389_fnagi_2023_1210585 crossref_primary_10_1080_23279095_2023_2259035 crossref_primary_10_3389_fnagi_2022_903794 crossref_primary_10_3389_fnut_2024_1467751 crossref_primary_10_3390_jcm14155261 crossref_primary_10_1080_10942912_2023_2243050 crossref_primary_10_1016_j_compbiomed_2024_108979 crossref_primary_10_1080_17483107_2022_2075477 crossref_primary_10_3389_fnagi_2022_995330 crossref_primary_10_1016_j_arr_2023_102120 crossref_primary_10_2196_73074 crossref_primary_10_3390_brainsci12101399 crossref_primary_10_3390_nu15020386 crossref_primary_10_1007_s12031_022_02052_4 crossref_primary_10_1007_s12035_023_03770_5 crossref_primary_10_1097_MS9_0000000000000951 crossref_primary_10_1016_j_neurol_2023_07_002 crossref_primary_10_1016_j_jamda_2024_105084 crossref_primary_10_1016_j_heliyon_2024_e27429 crossref_primary_10_3389_fnagi_2020_594002 crossref_primary_10_3390_nu14194198 crossref_primary_10_3389_fpsyg_2025_1525172 crossref_primary_10_1177_13872877251313816 crossref_primary_10_1038_s41598_023_49162_6 crossref_primary_10_1177_20552076241282237 crossref_primary_10_3389_fnagi_2024_1345251 crossref_primary_10_3389_fpsyt_2023_1081209 crossref_primary_10_3389_fnagi_2023_1227112 crossref_primary_10_3390_nu16234121 crossref_primary_10_1159_000540021 crossref_primary_10_3233_JAD_215654 crossref_primary_10_3389_fpubh_2025_1576629 crossref_primary_10_3389_fnhum_2022_1010076 crossref_primary_10_3390_ijms26104735 crossref_primary_10_1186_s12888_025_07228_x crossref_primary_10_3389_fpsyt_2022_960648 crossref_primary_10_1186_s12911_023_02238_9 crossref_primary_10_3389_fcvm_2022_1107544 crossref_primary_10_3390_biom12091310 crossref_primary_10_1016_j_psc_2022_07_010 crossref_primary_10_3389_fpubh_2023_1165753 crossref_primary_10_1016_j_gerinurse_2023_03_028 crossref_primary_10_3389_fnut_2025_1578181 crossref_primary_10_3389_fnins_2023_1222751 crossref_primary_10_1111_psyg_12899 crossref_primary_10_1002_brb3_2709 crossref_primary_10_1136_heartjnl_2024_325486 crossref_primary_10_3390_jcm13185367 crossref_primary_10_1152_jn_00408_2024 crossref_primary_10_3390_s25072081 crossref_primary_10_1038_s41598_023_30021_3 crossref_primary_10_1080_00207454_2022_2082966 crossref_primary_10_3233_JAD_230901 crossref_primary_10_1002_trc2_70153 crossref_primary_10_3390_brainsci14040381 crossref_primary_10_1192_j_eurpsy_2021_2230 crossref_primary_10_1016_j_exger_2025_112834 crossref_primary_10_1088_1757_899X_1320_1_012019 crossref_primary_10_1016_j_jpba_2025_116818 crossref_primary_10_3389_fpubh_2025_1561263 crossref_primary_10_1016_j_exger_2023_112355 crossref_primary_10_3390_ijms23031217 crossref_primary_10_1016_j_ctcp_2022_101626 crossref_primary_10_1159_000514105 crossref_primary_10_1186_s13063_023_07813_z crossref_primary_10_1080_01634372_2024_2338066 crossref_primary_10_31083_j_jin2206152 crossref_primary_10_1111_jocn_16993 crossref_primary_10_3390_ijms25094639 crossref_primary_10_3390_biomedicines11112963 crossref_primary_10_3390_ijms251910757 crossref_primary_10_1016_j_bspc_2024_106646 crossref_primary_10_1016_j_crad_2022_06_007 crossref_primary_10_1016_j_jad_2022_01_107 crossref_primary_10_1097_MD_0000000000022021 crossref_primary_10_1016_j_bspc_2022_104301 crossref_primary_10_3390_neurolint14020034 crossref_primary_10_1002_alz_13576 crossref_primary_10_1016_j_bbi_2022_12_013 crossref_primary_10_2196_67437 crossref_primary_10_3233_NRE_230127 crossref_primary_10_3233_JAD_230485 crossref_primary_10_3389_fpubh_2022_939150
Cites_doi	10.1080/09602011.2015.1048694 10.1016/S1474-4422(14)70136-X 10.1016/S0140-6736(97)01007-6 10.1038/mp.2011.147 10.1080/09602011.2016.1216000 10.1080/13607863.2012.732033 10.1016/j.jalz.2011.01.002 10.1093/brain/aws277 10.1186/alzrt269 10.1192/bjp.140.6.566 10.1016/j.bandc.2009.01.009 10.1155/2009/698156 10.1016/j.neuroimage.2006.06.021 10.1111/j.1532-5415.2005.53221.x 10.1016/j.bandc.2008.11.003 10.1016/j.neuropsychologia.2013.02.014 10.1111/j.1365-2796.2004.01388.x 10.1001/archneurol.2011.125 10.1097/WAD.0b013e31816bbd27 10.1001/archneurol.2009.106 10.1097/WAD.0000000000000145 10.1212/01.wnl.0000171450.97464.49 10.1016/j.neurobiolaging.2017.04.025 10.1038/nrn3338 10.1212/WNL.0000000000004826 10.1016/j.neuropsychologia.2010.05.010 10.1016/j.neurobiolaging.2009.01.013 10.1523/JNEUROSCI.4740-11.2011 10.1097/JGP.0b013e3181df49fb 10.1016/j.jalz.2011.03.008 10.1001/archneur.58.3.397 10.1111/j.1600-0447.2011.01801.x 10.1212/WNL.0b013e3181eb5872 10.1017/S135561771400068X 10.1016/j.cger.2013.07.003 10.1515/revneuro-2015-0019 10.1001/archneur.56.3.303 10.1097/JGP.0b013e318181f9b1 10.1017/S1355617714000782 10.1016/j.cmpb.2014.01.019 10.1371/journal.pmed.1002254 10.1007/s00406-014-0571-z 10.1038/nature25456 10.3233/JAD-140405 10.1001/archpsyc.63.5.530 10.1093/geronb/gbx100 10.1017/S1355617709990270 10.1159/000442261 10.1159/000234911 10.1111/jgs.12742 10.1088/1741-2560/9/3/036007 10.1017/S1355617708080521 10.1016/S1474-4422(12)70191-6 10.1016/j.jns.2007.04.054 10.1016/j.arr.2013.01.006 10.1016/j.neuropsychologia.2011.03.012 10.1016/0197-4580(95)00021-6 10.1371/journal.pone.0019584 10.1159/000096316 10.1007/s11065-015-9312-y 10.1016/j.neuropsychologia.2016.06.035 10.1017/S1041610212000695 10.3233/JAD-2011-111076 10.1080/13607863.2012.751582 10.1186/s12889-015-2426-6 10.1080/13607863.2012.747083 10.1111/joim.12190 10.1159/000022163 10.1017/S0714980809090126 10.1038/nrneurol.2012.241 10.1080/13803390802595568 10.1016/j.dadm.2017.07.001 10.1111/jgs.15192 10.1016/j.neuropsychologia.2007.05.023 10.3233/JAD-130830 10.1002/ddr.430150203 10.1111/joim.12191 10.1016/j.neurobiolaging.2007.03.024 10.1001/archneur.58.12.1985 10.1037/0894-4105.22.2.177 10.1001/archneurol.2009.307 10.1097/JGP.0b013e31826ce640 10.1016/0022-3956(75)90026-6 10.1080/09602011.2017.1361843 10.4061/2011/539621 10.1016/j.jalz.2016.09.009 10.1002/hipo.22658 10.1111/acps.12008 10.1093/geront/gnv030 10.1080/13825585.2014.915918 10.1159/000278422 10.1371/journal.pone.0053922 10.1016/j.dadm.2015.11.007 10.1016/j.jagp.2015.07.007 10.1371/journal.pcbi.1000106 10.1111/1467-9280.t01-1-01430 10.1097/01.wad.0000213849.51495.d9 10.1017/S1041610294001626 10.1017/S1041610212002177 10.1016/j.neurobiolaging.2014.03.031 10.1016/j.neurobiolaging.2016.09.011 10.1080/09602010701409684
ContentType	Journal Article
Copyright	Cambridge University Press 2019
Copyright_xml	– notice: Cambridge University Press 2019
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. M0S M2M PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8
DOI	10.1017/S1092852918001347
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Psychology Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) ProQuest One Academic (New) MEDLINE - Academic
DatabaseTitleList	ProQuest One Psychology MEDLINE CrossRef MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	2165-6509
EndPage	87
ExternalDocumentID	30651152 10_1017_S1092852918001347
Genre	Journal Article Review
GroupedDBID	--- -E. .GJ 09C 09E 0E1 0R~ 123 29B 36B 53G 5VS 6PF 7X7 8FI 8FJ AAAZR AABES AABWE AACJH AAGFV AAKTX AARAB AASVR AATMM AAUKB AAWTL AAXMD AAYXX ABBXD ABBZL ABGDZ ABJNI ABKKG ABQTM ABROB ABUWG ABVKB ABVZP ABWCF ABXAU ABXHF ABZCX ABZUI ACBMC ACDLN ACETC ACGFO ACGFS ACIMK ACRPL ACUIJ ACYZP ACZBM ACZUX ADAZD ADDNB ADFEC ADKIL ADNMO ADOVH ADOVT ADVJH AEBAK AEHGV AEMFK AEMTJ AENCP AENEX AENGE AEPLO AEYHU AFFHD AFFUJ AFKQG AFKRA AFLOS AFLVW AFUTZ AFZFC AGABE AGJUD AGLWM AGQPQ AHIPN AHLTW AHQXX AHRGI AIGNW AIHIV AIOIP AISIE AJCYY AJPFC AJQAS AKMAY AKZCZ ALMA_UNASSIGNED_HOLDINGS ANPSP AQJOH ARABE ARZZG ATUCA AUXHV AYIQA AZGZS AZQEC BBLKV BCGOX BENPR BESQT BGHMG BJBOZ BLZWO BMAJL BQFHP BRIRG C0O C1A C45 CBIIA CCPQU CCQAD CCUQV CFAFE CFBFF CGQII CHEAL CITATION CJCSC DC4 DOHLZ DWQXO E3Z EBS EGQIC EJD EMB EMOBN F5P FYUFA GNUQQ HG- HMCUK HZ~ I.6 I.7 I.9 IH6 IOEEP IOO IPYYG IS6 I~P JHPGK JQKCU JVRFK KAFGG KCGVB KFECR LHUNA LW7 M-V M2M NIKVX NZEOI O9- OVD P2P PHGZM PHGZT PSYQQ RCA ROL RR0 S6- S6U SAAAG SJN SY4 T9M TEORI TR2 UKHRP UT1 UU6 WFFJZ ZDLDU ZJOSE ZMEZD ZYDXJ ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 PUEGO
ID	FETCH-LOGICAL-c438t-ac48e48489e70ac91fd006523aee0ea3e8168bb683de25ebccd44564a5fa21213
IEDL.DBID	BENPR
ISICitedReferencesCount	351
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000461618200008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1092-8529
IngestDate	Fri Sep 05 12:45:38 EDT 2025 Tue Oct 07 07:30:12 EDT 2025 Thu Apr 03 07:04:18 EDT 2025 Tue Nov 18 22:33:04 EST 2025 Sat Nov 29 04:26:14 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	neuropsychological assessment exercise and diet interventions biomarkers tau Amyloid mild cognitive impairment memory strategy training neuroimaging
Language	English
License	https://www.cambridge.org/core/terms
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c438t-ac48e48489e70ac91fd006523aee0ea3e8168bb683de25ebccd44564a5fa21213
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
ORCID	0000-0002-5979-2220
OpenAccessLink	https://www.cambridge.org/core/services/aop-cambridge-core/content/view/9E28EC622A1911D82E18E4023811D79D/S1092852918001347a.pdf/div-class-title-state-of-the-science-on-mild-cognitive-impairment-mci-div.pdf
PMID	30651152
PQID	2788151790
PQPubID	5528237
PageCount	10
ParticipantIDs	proquest_miscellaneous_2179402949 proquest_journals_2788151790 pubmed_primary_30651152 crossref_citationtrail_10_1017_S1092852918001347 crossref_primary_10_1017_S1092852918001347
PublicationCentury	2000
PublicationDate	2019-02-01
PublicationDateYYYYMMDD	2019-02-01
PublicationDate_xml	– month: 02 year: 2019 text: 2019-02-01 day: 01
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: New York
PublicationTitle	CNS spectrums
PublicationTitleAlternate	CNS Spectr
PublicationYear	2019
Publisher	Cambridge University Press
Publisher_xml	– name: Cambridge University Press
References	Dauwels (S1092852918001347_ref55) 2011; 2011 S1092852918001347_ref34 S1092852918001347_ref35 S1092852918001347_ref36 S1092852918001347_ref37 S1092852918001347_ref30 S1092852918001347_ref31 S1092852918001347_ref32 S1092852918001347_ref33 S1092852918001347_ref111 S1092852918001347_ref49 S1092852918001347_ref45 S1092852918001347_ref46 S1092852918001347_ref47 S1092852918001347_ref48 S1092852918001347_ref41 (S1092852918001347_ref15) 2013 S1092852918001347_ref42 S1092852918001347_ref43 S1092852918001347_ref44 Ritchie (S1092852918001347_ref39) 2017 Sone (S1092852918001347_ref63) 2017; 9 S1092852918001347_ref16 S1092852918001347_ref17 S1092852918001347_ref18 S1092852918001347_ref19 S1092852918001347_ref12 S1092852918001347_ref13 S1092852918001347_ref14 S1092852918001347_ref96 S1092852918001347_ref97 S1092852918001347_ref98 S1092852918001347_ref10 S1092852918001347_ref11 S1092852918001347_ref99 S1092852918001347_ref92 S1092852918001347_ref93 S1092852918001347_ref94 S1092852918001347_ref95 S1092852918001347_ref90 S1092852918001347_ref91 S1092852918001347_ref27 S1092852918001347_ref28 S1092852918001347_ref29 S1092852918001347_ref23 S1092852918001347_ref24 S1092852918001347_ref25 S1092852918001347_ref26 S1092852918001347_ref9 S1092852918001347_ref20 S1092852918001347_ref21 S1092852918001347_ref8 S1092852918001347_ref7 S1092852918001347_ref22 Zhang (S1092852918001347_ref38) 2014 S1092852918001347_ref2 S1092852918001347_ref1 S1092852918001347_ref6 S1092852918001347_ref5 S1092852918001347_ref4 S1092852918001347_ref3 S1092852918001347_ref78 S1092852918001347_ref79 S1092852918001347_ref74 S1092852918001347_ref75 S1092852918001347_ref76 S1092852918001347_ref77 S1092852918001347_ref70 S1092852918001347_ref71 S1092852918001347_ref72 S1092852918001347_ref73 Jennings (S1092852918001347_ref110) 2015 Anderson (S1092852918001347_ref103) 2012 S1092852918001347_ref89 S1092852918001347_ref85 S1092852918001347_ref86 S1092852918001347_ref87 S1092852918001347_ref81 S1092852918001347_ref82 S1092852918001347_ref83 S1092852918001347_ref84 S1092852918001347_ref80 S1092852918001347_ref105 S1092852918001347_ref104 S1092852918001347_ref102 S1092852918001347_ref101 S1092852918001347_ref100 Ritchie (S1092852918001347_ref40) 2014; 10 S1092852918001347_ref56 S1092852918001347_ref109 S1092852918001347_ref108 S1092852918001347_ref57 S1092852918001347_ref58 S1092852918001347_ref107 S1092852918001347_ref59 S1092852918001347_ref106 S1092852918001347_ref52 S1092852918001347_ref53 S1092852918001347_ref54 S1092852918001347_ref50 S1092852918001347_ref51 Schoemaker (S1092852918001347_ref88) 2016; 2 S1092852918001347_ref67 S1092852918001347_ref68 S1092852918001347_ref69 S1092852918001347_ref64 S1092852918001347_ref65 S1092852918001347_ref66 S1092852918001347_ref60 S1092852918001347_ref61 S1092852918001347_ref62
References_xml	– ident: S1092852918001347_ref108 doi: 10.1080/09602011.2015.1048694 – ident: S1092852918001347_ref32 doi: 10.1016/S1474-4422(14)70136-X – ident: S1092852918001347_ref7 doi: 10.1016/S0140-6736(97)01007-6 – ident: S1092852918001347_ref34 doi: 10.1038/mp.2011.147 – ident: S1092852918001347_ref106 doi: 10.1080/09602011.2016.1216000 – ident: S1092852918001347_ref28 doi: 10.1080/13607863.2012.732033 – ident: S1092852918001347_ref17 doi: 10.1016/j.jalz.2011.01.002 – ident: S1092852918001347_ref74 doi: 10.1093/brain/aws277 – ident: S1092852918001347_ref2 doi: 10.1186/alzrt269 – ident: S1092852918001347_ref8 doi: 10.1192/bjp.140.6.566 – ident: S1092852918001347_ref85 doi: 10.1016/j.bandc.2009.01.009 – ident: S1092852918001347_ref35 doi: 10.1155/2009/698156 – ident: S1092852918001347_ref75 doi: 10.1016/j.neuroimage.2006.06.021 – ident: S1092852918001347_ref60 doi: 10.1111/j.1532-5415.2005.53221.x – ident: S1092852918001347_ref86 doi: 10.1016/j.bandc.2008.11.003 – ident: S1092852918001347_ref87 doi: 10.1016/j.neuropsychologia.2013.02.014 – ident: S1092852918001347_ref13 doi: 10.1111/j.1365-2796.2004.01388.x – ident: S1092852918001347_ref96 doi: 10.1001/archneurol.2011.125 – ident: S1092852918001347_ref77 doi: 10.1097/WAD.0b013e31816bbd27 – ident: S1092852918001347_ref20 doi: 10.1001/archneurol.2009.106 – ident: S1092852918001347_ref69 doi: 10.1097/WAD.0000000000000145 – volume-title: Diagnostic and Statistical Manual of Mental Disorders year: 2013 ident: S1092852918001347_ref15 – ident: S1092852918001347_ref44 doi: 10.1212/01.wnl.0000171450.97464.49 – ident: S1092852918001347_ref61 doi: 10.1016/j.neurobiolaging.2017.04.025 – ident: S1092852918001347_ref111 – ident: S1092852918001347_ref76 doi: 10.1038/nrn3338 – ident: S1092852918001347_ref16 doi: 10.1212/WNL.0000000000004826 – ident: S1092852918001347_ref5 – ident: S1092852918001347_ref79 doi: 10.1016/j.neuropsychologia.2010.05.010 – ident: S1092852918001347_ref37 doi: 10.1016/j.neurobiolaging.2009.01.013 – ident: S1092852918001347_ref45 doi: 10.1523/JNEUROSCI.4740-11.2011 – ident: S1092852918001347_ref47 doi: 10.1097/JGP.0b013e3181df49fb – ident: S1092852918001347_ref14 doi: 10.1016/j.jalz.2011.03.008 – ident: S1092852918001347_ref9 doi: 10.1001/archneur.58.3.397 – ident: S1092852918001347_ref49 doi: 10.1111/j.1600-0447.2011.01801.x – ident: S1092852918001347_ref89 doi: 10.1212/WNL.0b013e3181eb5872 – ident: S1092852918001347_ref72 doi: 10.1017/S135561771400068X – ident: S1092852918001347_ref19 doi: 10.1016/j.cger.2013.07.003 – ident: S1092852918001347_ref58 doi: 10.1515/revneuro-2015-0019 – ident: S1092852918001347_ref11 doi: 10.1001/archneur.56.3.303 – ident: S1092852918001347_ref25 doi: 10.1097/JGP.0b013e318181f9b1 – ident: S1092852918001347_ref101 doi: 10.1017/S1355617714000782 – ident: S1092852918001347_ref52 doi: 10.1016/j.cmpb.2014.01.019 – ident: S1092852918001347_ref41 doi: 10.1371/journal.pmed.1002254 – ident: S1092852918001347_ref68 doi: 10.1007/s00406-014-0571-z – start-page: CD010803 year: 2017 ident: S1092852918001347_ref39 article-title: CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) (Review) publication-title: Cochrane Database Syst Rev – ident: S1092852918001347_ref65 doi: 10.1038/nature25456 – ident: S1092852918001347_ref33 doi: 10.3233/JAD-140405 – ident: S1092852918001347_ref48 doi: 10.1001/archpsyc.63.5.530 – ident: S1092852918001347_ref23 doi: 10.1093/geronb/gbx100 – ident: S1092852918001347_ref105 doi: 10.1017/S1355617709990270 – ident: S1092852918001347_ref100 doi: 10.1159/000442261 – ident: S1092852918001347_ref71 doi: 10.1159/000234911 – ident: S1092852918001347_ref66 doi: 10.1111/jgs.12742 – ident: S1092852918001347_ref53 doi: 10.1088/1741-2560/9/3/036007 – ident: S1092852918001347_ref67 doi: 10.1017/S1355617708080521 – ident: S1092852918001347_ref90 doi: 10.1016/S1474-4422(12)70191-6 – ident: S1092852918001347_ref94 doi: 10.1016/j.jns.2007.04.054 – ident: S1092852918001347_ref59 doi: 10.1016/j.arr.2013.01.006 – ident: S1092852918001347_ref81 doi: 10.1016/j.neuropsychologia.2011.03.012 – start-page: CD010386 year: 2014 ident: S1092852918001347_ref38 article-title: 11)C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) publication-title: Cochrane Database Syst Rev – ident: S1092852918001347_ref56 doi: 10.1016/0197-4580(95)00021-6 – ident: S1092852918001347_ref50 doi: 10.1371/journal.pone.0019584 – ident: S1092852918001347_ref98 doi: 10.1159/000096316 – ident: S1092852918001347_ref27 doi: 10.1007/s11065-015-9312-y – ident: S1092852918001347_ref80 doi: 10.1016/j.neuropsychologia.2016.06.035 – ident: S1092852918001347_ref70 doi: 10.1017/S1041610212000695 – ident: S1092852918001347_ref97 doi: 10.3233/JAD-2011-111076 – ident: S1092852918001347_ref29 doi: 10.1080/13607863.2012.751582 – ident: S1092852918001347_ref31 doi: 10.1186/s12889-015-2426-6 – ident: S1092852918001347_ref21 doi: 10.1080/13607863.2012.747083 – ident: S1092852918001347_ref18 doi: 10.1111/joim.12190 – ident: S1092852918001347_ref46 doi: 10.1159/000022163 – ident: S1092852918001347_ref24 doi: 10.1017/S0714980809090126 – ident: S1092852918001347_ref4 doi: 10.1038/nrneurol.2012.241 – ident: S1092852918001347_ref83 doi: 10.1080/13803390802595568 – volume: 9 start-page: 35 year: 2017 ident: S1092852918001347_ref63 article-title: Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer’s disease: a combined positron emission tomography/magnetic resonance imaging study publication-title: Alzheimers Dement (Amst) doi: 10.1016/j.dadm.2017.07.001 – ident: S1092852918001347_ref99 doi: 10.1111/jgs.15192 – ident: S1092852918001347_ref73 doi: 10.1016/j.neuropsychologia.2007.05.023 – ident: S1092852918001347_ref95 doi: 10.3233/JAD-130830 – ident: S1092852918001347_ref10 doi: 10.1002/ddr.430150203 – ident: S1092852918001347_ref3 doi: 10.1111/joim.12191 – ident: S1092852918001347_ref57 doi: 10.1016/j.neurobiolaging.2007.03.024 – ident: S1092852918001347_ref12 doi: 10.1001/archneur.58.12.1985 – ident: S1092852918001347_ref84 doi: 10.1037/0894-4105.22.2.177 – ident: S1092852918001347_ref92 doi: 10.1001/archneurol.2009.307 – ident: S1092852918001347_ref22 doi: 10.1097/JGP.0b013e31826ce640 – ident: S1092852918001347_ref43 doi: 10.1016/0022-3956(75)90026-6 – ident: S1092852918001347_ref1 – ident: S1092852918001347_ref104 doi: 10.1080/09602011.2017.1361843 – volume: 2011 start-page: 539621 year: 2011 ident: S1092852918001347_ref55 article-title: Slowing and loss of complexity in Alzheimer’s EEG: two sides of the same coin? publication-title: Int J Alzheimers Dis doi: 10.4061/2011/539621 – ident: S1092852918001347_ref64 doi: 10.1016/j.jalz.2016.09.009 – ident: S1092852918001347_ref82 doi: 10.1002/hipo.22658 – ident: S1092852918001347_ref26 doi: 10.1111/acps.12008 – ident: S1092852918001347_ref30 doi: 10.1093/geront/gnv030 – ident: S1092852918001347_ref109 doi: 10.1080/13825585.2014.915918 – ident: S1092852918001347_ref36 doi: 10.1159/000278422 – ident: S1092852918001347_ref51 doi: 10.1371/journal.pone.0053922 – volume: 2 start-page: 132 year: 2016 ident: S1092852918001347_ref88 article-title: Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer disease publication-title: Alzheimers Dement (Amst) doi: 10.1016/j.dadm.2015.11.007 – volume-title: Living with Mild Cognitive Impairment: A Guide to Maximizing Brain Health and Reducing Risk of Dementia year: 2012 ident: S1092852918001347_ref103 – ident: S1092852918001347_ref91 doi: 10.1016/j.jagp.2015.07.007 – ident: S1092852918001347_ref54 doi: 10.1371/journal.pcbi.1000106 – volume: 10 start-page: CD008782 year: 2014 ident: S1092852918001347_ref40 article-title: Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) publication-title: Cochrane Database Syst Rev – ident: S1092852918001347_ref93 doi: 10.1111/1467-9280.t01-1-01430 – start-page: 252 volume-title: Remembering: Attributions, Processes, and Control in Human Memory. Essays in Honor of Larry Jacoby year: 2015 ident: S1092852918001347_ref110 – ident: S1092852918001347_ref78 doi: 10.1097/01.wad.0000213849.51495.d9 – ident: S1092852918001347_ref6 doi: 10.1017/S1041610294001626 – ident: S1092852918001347_ref107 doi: 10.1017/S1041610212002177 – ident: S1092852918001347_ref42 doi: 10.1016/j.neurobiolaging.2014.03.031 – ident: S1092852918001347_ref62 doi: 10.1016/j.neurobiolaging.2016.09.011 – ident: S1092852918001347_ref102 doi: 10.1080/09602010701409684
SSID	ssj0043783
Score	2.6488078
SecondaryResourceType	review_article
Snippet	Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10–15% of the population over the age of 65.... Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10-15% of the population over the age of 65....
SourceID	proquest pubmed crossref
SourceType	Aggregation Database Index Database Enrichment Source
StartPage	78
SubjectTerms	Alzheimer's disease Apolipoproteins - genetics Apolipoproteins - metabolism Biomarkers Cognitive Dysfunction - drug therapy Cognitive Dysfunction - genetics Cognitive Dysfunction - metabolism Cognitive Dysfunction - physiopathology Cortical Excitability Humans Mental depression Nootropic Agents - therapeutic use Older people
Title	State of the science on mild cognitive impairment (MCI)
URI	https://www.ncbi.nlm.nih.gov/pubmed/30651152 https://www.proquest.com/docview/2788151790 https://www.proquest.com/docview/2179402949
Volume	24
WOSCitedRecordID	wos000461618200008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2165-6509 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0043783 issn: 1092-8529 databaseCode: 7X7 dateStart: 20120601 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2165-6509 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0043783 issn: 1092-8529 databaseCode: BENPR dateStart: 20120601 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 2165-6509 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0043783 issn: 1092-8529 databaseCode: M2M dateStart: 20120601 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50FfHi-7G-iOBBhWI3SdvkJCqKgruIKOytpEkKC2uru6u_30ybroLoxUuhafpgmpn5OjP9BuCowzNjpbUB51EeOE0UgWBaB5kxieACQXBF4nqf9Hqi35cPPuA29mWVjU2sDLUpNcbIzyjynld8UuevbwF2jcLsqm-hMQtzyFTGWzB3ed17eGxsMWeJqEvspdP7iMomr4mk0TiIYx2BOAj7q3z3TL_Azcrt3Cz_94FXYMkDTnJRr5BVmLHFGix0fUp9HZIKbpIyJw4KEu8QSVmQl8HQkGl1EcHfKQcjjCWS4-7V3ckGPN9cP13dBr6bQqA5E5NAaS4sd_KXNgmVlp3cIP6gTFkbWsUsduDIslgwY2lkM60NR64ZFeWKIvHbJrSKsrDbQOKYhkyLOMqE5LGKVa5Co6S0HZYZxmgbwkaSqfZU49jxYpjWNWVJ-kP4bTidnvJa82z8NXmvEXnqVW6cfsm7DYfTw05ZMAOiClu-uzlofkIquWzDVv1ap3dz304OfEZ05--L78Kiw0yyLtzeg9Zk9G73YV5_TAbj0QHMJv2k2ooDvxbdXpd2PwEhV9_O
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VUtFeoEChW0pxJZCgUkTWdhL7gBDqh7rq7opDK-0tOPZEWqlNyu62FX-K31hPvkBC7a0HronjWJnJm2d7_AbgfV9mDjViIGWUB_5PVIES1gaZc4mSikhwJeI6TMZjNZno70vwuz0LQ2mVLSZWQO1KS2vknznpnld6Ul8vfwZUNYp2V9sSGrVbnOCvGz9lm38ZHHj7fuD86PB0_zhoqgoEVgq1CIyVCqUfh8YkNFb3c0dxmAuDGKIRSJUosixWwiGPMLPWSdJcMVFuOAmg-X4fwWOP4wmlkCWTboInRaLqhH7tUSbiut1FJYlqukjX-opYF1Vz-TsO3kFuqyB39Ox_-zzr8LSh0-xb7f_PYQmLF_Bk1CQMvISkItOszJknuqwJ96ws2MX03LEud4rRYdHpjFZK2cfR_uDTBpw9yLBfwXJRFrgJLI55KKyKo0xpGZvY5CZ0Rmvsi8wJwXsQtpZLbSOkTvU8ztM6Yy5J_zF2D_a6Ry5rFZH7Gm-3Jk4bQJmnf-zbg93utocC2t8xBZZXvg2Ba8i11D14XbtR9zY_M_TUOuJb93f-DlaPT0fDdDgYn7yBNc8OdZ2ivg3Li9kVvoUVe72Yzmc7lecz-PHQvnQLXyw5aQ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB5RihAX6JsFSl2JShQpIms7iX1AVQWsuoJdcQCJW-rYE2klSGB3AfHX-HV48tgiVeXGoVfHcazMeOazZ_wNwFZXZg41YiBllAd-JapACWuDzLlESUUguCJxPU6GQ3V-rk_m4KG9C0Npla1NrAy1Ky2dke9y4j2v-KR28yYt4uSg9-PqOqAKUhRpbctp1CpyhPd3fvs22esfeFl_47x3eLr_K2gqDARWCjUNjJUKpZ-TxiQ0VndzRz6ZC4MYohFIVSmyLFbCIY8ws9ZJ4l8xUW44kaH5cV_B60RGEVVPGPBB6wWkSFSd3K-9xYm4biOqRFdNjdTWVYTAqLLLU5_4D6BbObzeyv_8q97AcgOz2c96XbyFOSzeweKgSSR4D0kFslmZMw-AWQMDWFmwy9GFY7OcKkaXSEdjOkFl24P9_vcPcPYi0_4I80VZ4CqwOOahsCqOMqVlbGKTm9AZrbErMicE70DYSjG1DcE61fm4SOtMuiT9S_Ad2Jm9clWzizzXeaMVd9oYmkn6R9Yd-Dp77E0ExX1MgeWN70NGN-Ra6g58qlVq9jW_Y_SQO-Jrzw_-BRa9CqXH_eHROix50KjrzPUNmJ-Ob_AzLNjb6Wgy3qwWAYPfL61Kj2fGQiw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=State+of+the+science+on+mild+cognitive+impairment+%28MCI%29&rft.jtitle=CNS+spectrums&rft.au=Anderson%2C+Nicole+D&rft.date=2019-02-01&rft.issn=1092-8529&rft.volume=24&rft.issue=1&rft.spage=78&rft_id=info:doi/10.1017%2FS1092852918001347&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1092-8529&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1092-8529&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1092-8529&client=summon